We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drugmakers Offer Feedback on Drug Abuse and Dependence Labeling
Drugmakers Offer Feedback on Drug Abuse and Dependence Labeling
Pfizer and Janssen said the FDA’s draft guidance on drug abuse and dependence labeling for prescription drugs and biologics is good but needs some tweaking.